Advances in Relapsed/Refractory Myeloma: Keeping Pace With a Rapidly Evolving Treatment Landscape

This online program is based on a live satellite symposium covering the latest therapeutic strategies for the management of relapsed/refractory multiple myeloma including the latest clinical data on the safety and efficacy of emerging agents. Watch the on-demand webcast download the slidesets from the satellite symposium and read an expert commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

GlaxoSmithKline

Janssen administered by Scientific Affairs

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc.